Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Journal of Hematology & Oncology|May 29, 2016
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapyWeijie Ma, Barbara M Gilligan, Jianda Yuan, et al.
Heliyon|March 7, 2022
Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigenMichael Babich, Ankit Sharma, Tianhong Li, et al.
Journal of the National Cancer Center|October 20, 2025
Neuromuscular complications associated with cancer immunotherapyGe Xiong, Catherine Lomen-Herth, David Richman, et al.
Clinical Lung Cancer|January 8, 2021
Survival Trends of Metastatic Lung Cancer in California by Age at Diagnosis, Gender, Race/Ethnicity, and Histology, 1990-2014Tianhong Li, Kevin Pan, Amy K Ellinwood, et al.
Environmental Pollution (Barking, Essex : 1987)|April 30, 2019
Spatiotemporal distribution, source apportionment and ecological risk assessment of PBDEs and PAHs in the Guanlan River from rapidly urbanizing areas of Shenzhen, ChinaXinxiu Liang, Muhammad Junaid, Zhifen Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2011
The phosphatase inhibitor menadione (vitamin K3) protects cells from EGFR inhibition by erlotinib and cetuximabRoman Perez-Soler, Yiyu Zou, Tianhong Li, et al.
Cancer Chemotherapy and Pharmacology|January 9, 2009
Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinibYi-He Ling, Tianhong Li, Roman Perez-Soler, et al.
Cancers|January 11, 2025
Preclinical Models for Functional Precision Lung Cancer ResearchJie-Zeng Yu, Zsofia Kiss, Weijie Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in human non-small cell lung cancer cellsTianhong Li, Yi-He Ling, I David Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapiesTianhong Li, Hsing-Jien Kung, Philip C Mack, et al.
Pageof 13